Key facts
- This page summarizes Christopher Gene Thomas's Form 4 filing for Paycom Software, Inc. (PAYC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 May 2024, 16:33.
Christopher Gene Thomas - 10 May 2024 Form 4 Insider Report for Paycom Software, Inc. (PAYC)
- Reporting relationship
- Co-Chief Executive Officer
- Issuer ticker
- PAYC
- Reported as of
- 10 May 2024
- Net transaction value
- -$52,711
- SEC form
- 4
- Accepted by SEC
- 14 May 2024, 16:33:16 UTC
- Prior SEC filing
- 05 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Thomas
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher Gene Thomas filed Form 4 for Paycom Software, Inc. (PAYC) on 14 May 2024.
Change
- Previous filing in this sequence was filed on 05 Mar 2024.
- Current net transaction value: -$52,711.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PAYC
transaction
Common Stock
Tax liability
- Transaction value
- $52,711
- Shares
- -304
- Change %
- -0.59%
- Price
- $173.39
- Shares after
- 51,377
- Date
- 10 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares of common stock of Paycom Software, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of the following awards: (i) 164 shares of restricted stock granted to the reporting person on January 30, 2020; (ii) 163 shares of restricted stock granted to the reporting person on February 5, 2021; (iii) 150 shares of restricted stock granted to the reporting person on February 2, 2022; and (iv) 208 shares of restricted stock granted to the reporting person on February 4, 2023. No shares were issued or sold in this transaction.
Footnote F2
Consists of 25,273 unvested restricted stock units and 20,227 unvested shares of restricted stock.